Indicadores de inovação tecnológica na indústria farmacêutica brasileira no período de 2008 a 2017

Abstract

Innovation in the pharmaceutical industry is one of the most costly and risky processes, as it is directly dependent on scientific advances, skilled labor and high financial capital. It is, therefore, classified as technology-intensive and strongly based on science, so that innovative activities are decisive for the pattern of competition in this market. The central objective of this conclusion work is, from the theoretical perspective of neo-Schumpeterian authors, to identify the importance of technological training and forms of learning processes for the innovative process of productive activities and, finally, to understand what have been the characteristics of the innovative activities of the Brazilian pharmaceutical industry between 2008 and 2017 through the analysis of innovation indicators. It is therefore proposed, from a quantitative approach, to present an analysis on indicators of: innovation, dimension of innovation and efforts towards innovation, applied together with data from PINTEC (IBGE). Through them, it was possible to identify the Brazilian dependence on foreign advances, as well as a guarded behavior towards innovation, in which less than half of the companies in the pharmaceutical and pharmochemical sector are willing to innovate, and when they do, it is in a restrained and cautious way, allowing to assume here that the effort is aimed at keeping up with market and competition movements without necessarily looking for a new and disruptive item that would require high levels of research and development.